Dr. Xianfeng (Morgan) Xu focuses on preparing and prosecuting US patents and overseeing foreign patent procurement in biotechnology and life sciences. He also assists clients with patent portfolio management, IP transactions and due diligence, post-grant proceedings, and FDA regulatory matters. Dr. Xu has experience working with technologies from fields such as molecular diagnostics, microbiome therapy, gene therapy, biologics, small molecule therapeutics, bioenergy, and agricultural breeding and engineering.
Dr. Xu has more than 10 years of research experience in biotechnology specializing in molecular genetics, cell and developmental biology, and plant biology. Before joining the firm, Dr. Xu was a Chapman Fellow at Cold Spring Harbor Laboratory studying the role of cell-to-cell communication in stem cell signaling. He was also a LSRF Fellow of the Life Sciences Research Foundation. Dr. Xu published as the lead author in journals such as Science, Current Biology, PNAS, and Plant Cell.
Dr. Xu is fluent in both English and Chinese (Mandarin), and worked at the firm as a patent agent while pursuing his JD degree. He received an ABA/BNA award for Excellence in Intellectual Property Law from GW Law in 2017.
- JD, The George Washington University Law School, 2017, with honors
- PhD, Plant Biology, The Ohio State University, 2007
- BS, Biotechnology, Peking University, 2002
- District of Columbia
- US Patent and Trademark Office
- Chinese (Mandarin)